114 related articles for article (PubMed ID: 22158387)
21. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
Cohen AL; Sarid R
Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
[TBL] [Abstract][Full Text] [Related]
22. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
Pérez-Persona E; Mateo G; García-Sanz R; Mateos MV; de Las Heras N; de Coca AG; Hernández JM; Galende J; Martín-Nuñez G; Bárez A; Alonso JM; Martín A; López-Berges C; Orfao A; San Miguel JF; Vidriales MB
Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821
[TBL] [Abstract][Full Text] [Related]
23. Investigation of monoclonal gammopathy of undetermined significance: a single-centre study.
Simon Z; Sipka S; Gergely L; Csípö I; Illés A
Clin Lab Haematol; 2006 Jun; 28(3):164-9. PubMed ID: 16706932
[TBL] [Abstract][Full Text] [Related]
24. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S
Cancer; 2006 May; 106(10):2171-80. PubMed ID: 16598756
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies.
Galioto A; Morando F; Rosi S; Schipilliti M; Fasolato S; Magrin M; Frigo AC; Adami F; Cavallin M; Zanus G; Plebani M; Romano A; Sticca A; Cillo U; Gatta A; Angeli P
Transpl Int; 2012 Jan; 25(1):25-33. PubMed ID: 21999283
[TBL] [Abstract][Full Text] [Related]
26. [Monoclonal gammopathies of undetermined significance].
Krizalkovicová V; Maisnar V; Pour L; Radocha J; Hájek R
Klin Onkol; 2008; 21(4):160-4. PubMed ID: 19102222
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; Rajkumar SV
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.
Kaufmann H; Ackermann J; Odelga V; Sagaster V; Nösslinger T; Pfeilstöcker M; Keck A; Ludwig H; Gisslinger H; Drach J
Eur J Clin Invest; 2008 Jan; 38(1):53-60. PubMed ID: 18173551
[TBL] [Abstract][Full Text] [Related]
29. Overview of monoclonal gammopathies of undetermined significance.
Vogt RF; Marti GE
Br J Haematol; 2007 Dec; 139(5):687-9. PubMed ID: 18021082
[TBL] [Abstract][Full Text] [Related]
30. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
32. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
33. Activated protein C resistance as measured by residual factor V after Russell's viper venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls.
Zangari M; Berno T; Zhan F; Boucher KM; Tricot G; Fink L
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):420-3. PubMed ID: 21537162
[TBL] [Abstract][Full Text] [Related]
34. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.
Soltero L; Carbajal H; Xu J; McCarthy J; Suki WN; Gaber AO; Adrogué HE
Clin Transplant; 2012; 26(2):300-4. PubMed ID: 22044717
[TBL] [Abstract][Full Text] [Related]
35. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
McMaster ML; Caporaso N
Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
Bladé J; Rosiñol L; Cibeira MT; de Larrea CF
Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
[TBL] [Abstract][Full Text] [Related]
38. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
39. Genomic aberrations and survival of patients with light-chain-only multiple myeloma undergoing autologous stem cell transplantation.
Jiang N; Qi C; Trieu Y; Reece D; Chang H
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1790-5. PubMed ID: 21658460
[TBL] [Abstract][Full Text] [Related]
40. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.
Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H
Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]